Correspondence 0001493152-25-003589 from CEMTREX INC (CETX, CETXP) (CIK 0001435064) (CETX)

CEMTREX INC (CETX, CETXP) (CIK 0001435064)
Date: Jan. 24, 2025 · CIK: 0001435064 · Accession: 0001493152-25-003589

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-37464

Date

January 13, 2025

Author

/s/

Form

CORRESP

Company

CEMTREX INC (CETX, CETXP) (CIK 0001435064)

Letter

Via EDGAR United States Securities and Exchange Commission Attention: Bradley Ecker CEMTREX INC Schedule 14C Information Statement Filed on January 13, 2025 File No. 001-37464

Dear Mr. Ecker:

I write on behalf of Cemtrex, Inc. (the “Company”) in response to Staff’s letter of January 23, 2025, by the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”) regarding the above-referenced Schedule 14C Information Statement, filed January 13, 2025 (the Comment Letter”).

Paragraph numbering used for each response corresponds to the numbering used in the Comment letter.

Schedule 14C Information Statement filed January 13, 2025

General

1. We note a number of reverse stock splits in the past several months. Please revise the disclosure in the information statement to provide a materially complete explanation of the changes to, and the amount of, common stock outstanding and common stock underlying your warrants following the reverse stock splits.

In response to this comment, the Company revised its disclosures to provide an explanation of the changes to its common stock outstanding and warrants outstanding as a result of the Company reverse stock split transactions.

Sincerely
/s/
Saagar Govil

Show Raw Text

CORRESP
1
filename1.htm

CEMTREX
INC

135
Fell Court

Hauppauge,
NY 11788

Via
EDGAR

January
24, 2025

United
States Securities and Exchange Commission

100
F Street, N.E. Mailstop 3720

Washington
D.C., 20549-7010

Attention:
Bradley Ecker

CEMTREX
INC

Schedule
14C Information Statement

Filed
on January 13, 2025

File
No. 001-37464

Dear
Mr. Ecker:

I
write on behalf of Cemtrex, Inc. (the “Company”) in response to Staff’s letter of January 23, 2025, by the Division
of Corporation Finance of the United States Securities and Exchange Commission (the “Commission”) regarding the above-referenced
Schedule 14C Information Statement, filed January 13, 2025 (the Comment Letter”).

Paragraph
numbering used for each response corresponds to the numbering used in the Comment letter.

Schedule
14C Information Statement filed January 13, 2025

General

  1.
  We note a number of reverse stock
splits in the past several months. Please revise the disclosure in the information statement to provide a materially complete explanation
of the changes to, and the amount of, common stock outstanding and common stock underlying your warrants following the reverse stock
splits.

In
response to this comment, the Company revised its disclosures to provide an explanation of the changes to its common stock outstanding
and warrants outstanding as a result of the Company reverse stock split transactions.

Sincerely

  /s/
  Saagar Govil

  Saagar Govil

  Chief Executive Officer

SecProbe.io